BISMUTH ARSPHENAMINE SULPHONATE: CLINICAL OBSERVATIONS ON A NEW ARSPHENAMINE SYNTHETIC IN THE TREATMENT OF SYPHILIS

The Journal of the American Medical Association, October 29, 1927. Extract. Fair. 1st printing. 4to, pp. 1500-1505. This lecture appeared in Vol. 89 No. 18 of The Journal of the American Medical Association. "The clinical testing of an arsphenamine in the treatment of syphilis can hardly reach finality at the hands of a single observer, nor can the validity of conclusions be established short of years of observation. This should be borne in mind as we briefly recite a two years' experience with a new arsphenamine synthetic, bismuth arsphenamine sulphonate, submitted to us in July, 1925, for clinical testing by its originator, Prof. George W. Raiziss. We take this occasion, too, to say that comparisons made by different observers are discussable intelligently only if the modes of administration of a new drug and the technic of its employment in the disease in different clinics bear some resemblance to one another's detail too often forgotten in clinical as well as in scientific study, and notably illustrated by reported experience with sodium cacodylate and, more recently, sulpharsphenamine. Manufacturers' products will differ in spite of standard..." Also included with this extract is Diagnosis of Intestinal Amebiasis bt W.M. James; Heart Disease as Seen in a Southern Clinic by Charles T. Stone; Tumors of thed Cauda Equina and Spinal Cord by George E. Bennett; Migraine by C.L. Hartsock; Value of Intravenous Injections of Dextrose by George Pfahler; Mental Aspect of Leprosy by L. L. Cazenavette; The Oxidative Destruction ofVitamins A & E by H.A. Mattill; Drunkenness by Emil Bogen; Disbound from the journal. Edges frayed.